Browse > Article
http://dx.doi.org/10.5090/jcs.20.140

Meta-Analysis of Limited Thymectomy versus Total Thymectomy for Masaoka Stage I and II Thymoma  

Pulle, Mohan Venkatesh (Centre for Chest Surgery, Sir Ganga Ram Hospital)
Asaf, Belal Bin (Centre for Chest Surgery, Sir Ganga Ram Hospital)
Puri, Harsh Vardhan (Centre for Chest Surgery, Sir Ganga Ram Hospital)
Bishnoi, Sukhram (Centre for Chest Surgery, Sir Ganga Ram Hospital)
Kumar, Arvind (Centre for Chest Surgery, Sir Ganga Ram Hospital)
Publication Information
Journal of Chest Surgery / v.54, no.2, 2021 , pp. 127-136 More about this Journal
Abstract
Background: This meta-analysis aimed to evaluate the incidence of tumor recurrence, postoperative myasthenia gravis, postoperative complications, and overall survival after limited versus total thymectomy for Masaoka stage I and II thymoma. Methods: A systematic search of the literature was conducted using the PubMed, Embase, MEDLINE, and Cochrane databases to identify relevant studies that compared limited and total thymectomy in Masaoka stage I-II patients. The quality of the included observational studies was assessed using the Newcastle-Ottawa Scale. The results of the meta-analysis were expressed as log-transformed odds ratios (log ORs), with 95% confidence intervals (CIs). Results: Seven observational studies with a total of 2,310 patients were included in the meta-analysis. There was an overall non-significant difference in favor of total thymectomy in terms of tumor recurrence (pooled log OR, 0.40; 95% CI, -0.07 to 0.87; p=0.10; I2=0%) and postoperative myasthenia gravis (pooled log OR, 0.12; 95% CI, -1.08 to 1.32; p=0.85; I2=22.6%). However, an overall non-significant difference was found in favor of limited thymectomy with respect to postoperative complications (pooled log OR, -0.21; 95% CI, -1.08 to 0.66; p=0.64; I2=36.1%) and overall survival (pooled log OR, -0.01; 95% CI, -0.68 to 0.66; p=0.98; I2=47.8%). Conclusion: Based on the results of this systematic review and meta-analysis, limited thymectomy as a treatment for stage I and II thymoma shows similar oncologic outcomes to total thymectomy.
Keywords
Limited thymectomy; Total thymectomy; Meta-analysis; Masaoka-Koga stage I & II thymoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wilkins KB, Sheikh E, Green R, et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999;230:562-72.   DOI
2 Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9.   DOI
3 Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.   DOI
4 Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-6.   DOI
5 Takeo S, Tsukamoto S, Kawano D, Katsura M. Outcome of an original video-assisted thoracoscopic extended thymectomy for thymoma. Ann Thorac Surg 2011;92:2000-5.   DOI
6 Weksler B, Tavares J, Newhook TE, Greenleaf CE, Diehl JT. Robot-assisted thymectomy is superior to transsternal thymectomy. Surg Endosc 2012;26:261-6.   DOI
7 Okumura M, Ohta M, Takeuchi Y, et al. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer. J Thorac Cardiovasc Surg 2003;126:1922-8.   DOI
8 Toker A, Sonett J, Zielinski M, Rea F, Tomulescu V, Detterbeck FC. Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol 2011;6:S1739-42.   DOI
9 Ruffini E, Filosso PL, Guerrera F, Lausi P, Lyberis P, Oliaro A. Optimal surgical approach to thymic malignancies: new trends challenging old dogmas. Lung Cancer 2018;118:161-70.   DOI
10 Sun XG, Wang YL, Liu YH, Zhang N, Yin XL, Zhang WJ. Myasthenia gravis appearing after thymectomy. J Clin Neurosci 2011;18:57-60.   DOI
11 Odaka M, Akiba T, Yabe M, et al. Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma. Eur J Cardiothorac Surg 2010;37:824-6.   DOI
12 Onuki T, Ishikawa S, Iguchi K, et al. Limited thymectomy for stage I or II thymomas. Lung Cancer 2010;68:460-5.   DOI
13 Tseng YC, Hsieh CC, Huang HY, et al. Is thymectomy necessary in nonmyasthenic patients with early thymoma? J Thorac Oncol 2013;8:952-8.   DOI
14 Nakagawa K, Asamura H, Sakurai H, Watanabe S, Tsuta K. Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol 2014;109:179-83.   DOI
15 Rusidanmu A, Huang S, Lv X. Is thymomectomy sufficient for non-myasthenic early stage thymoma patients?: a retrospective, single center experience. Thorac Cancer 2018;9:88-93.   DOI
16 Gu Z, Fu J, Shen Y, et al. Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis. J Thorac Dis 2016;8:680-6.   DOI
17 Sakamaki Y, Oda T, Kanazawa G, Shimokawa T, Kido T, Shiono H. Intermediate-term oncologic outcomes after video-assisted thoracoscopic thymectomy for early-stage thymoma. J Thorac Cardiovasc Surg 2014;148:1230-7.   DOI
18 Tassi V, Ceccarelli S, Zannori C, et al. Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? J Thorac Dis 2017;9:3817-24.   DOI
19 Narm KS, Lee CY, Do YW, et al. Limited thymectomy as a potential alternative treatment option for early-stage thymoma: a multi-institutional propensity-matched study. Lung Cancer 2016;101:22-7.   DOI
20 Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336-41.   DOI
21 Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006;295:676-80.   DOI
22 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.   DOI
23 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.   DOI
24 Wells GA, Shea B, O'Connell D, et al. 2011 The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis [Internet]. Ottawa (ON): Ottawa Hospital Research Institute; 2011 [cited 2020 May 27]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
25 Huang J, Detterbeck FC, Wang Z, Loehrer PJ Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol 2010;5:2017-23.   DOI
26 Suzuki H, Yoshida S, Hiroshima K, Nakatani Y, Yoshino I. Synchronous multiple thymoma: report of three cases. Surg Today 2010;40:456-9.   DOI
27 Ito M, Fujimura S, Monden Y, et al. A retrospective group study on post-thymectomy myasthenia gravis. Nihon Kyobu Geka Gakkai Zasshi 1992;40:189-93.
28 Nakagawa K, Yokoi K, Nakajima J, et al. Is thymomectomy alone appropriate for stage I (T1N0M0) thymoma?: results of a propensity-score analysis. Ann Thorac Surg 2016;101:520-6.   DOI
29 Mori T, Nomori H, Ikeda K, et al. Three cases of multiple thymoma with a review of the literature. Jpn J Clin Oncol 2007;37:146-9.   DOI